P. aeruginosa LPS stimulates calcium signaling and chloride secretion via CFTR in human bronchial epithelial cells  J.M. Buyck, V. Verriere, R. Benmahdi,

Slides:



Advertisements
Similar presentations
Bioelectric effects of quinine on polarized airway epithelial cells
Advertisements

The prevalence of “risky behaviour” in adults with cystic fibrosis
Christopher C. Miller, Christopher A
CFTR stabilizes ENaC at the plasma membrane
Jay R. Thiagarajah, Talmage Broadbent, Emily Hsieh, Alan S. Verkman 
Deleterious impact of hyperglycemia on cystic fibrosis airway ion transport and epithelial repair  Claudia Bilodeau, Olivier Bardou, Émilie Maillé, Yves.
Neil E. Alexis, Marianne S. Muhlebach, David B. Peden, Terry L. Noah 
Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel  Emanuela Pesce, Giulia Gorrieri,
Stimulation of β2-adrenergic receptor increases CFTR function and decreases ATP levels in murine hematopoietic stem/progenitor cells  Teresa Trotta, Lorenzo.
Bioelectric effects of quinine on polarized airway epithelial cells
The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response  Kai Jiang, Sen Jiao, Megan Vitko, Rebecca Darrah,
Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25- dihydroxyvitamin D3  Sunghan Yim, Puneet Dhawan, Chandran Ragunath, Sylvia.
Effect of VX-770 (Ivacaftor) and OAG on Ca2+ influx and CFTR activity in G551D and F508del-CFTR expressing cells  Laura Vachel, Caroline Norez, Frédéric.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Ambra Gianotti, Valeria Capurro, Paolo Scudieri, Luis J. V
Etienne Roux, Marko Marhl  Biophysical Journal 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Successful treatment of cepacia syndrome
On the measurement of the functional properties of the CFTR
Partial Inhibition of Sarcoplasmic Reticulum Ca Release Evokes Long-Lasting Ca Release Events in Ventricular Myocytes: Role of Luminal Ca in Termination.
Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation  Venkateshwar Mutyam,
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Nadav Traeger, Qiuhu Shi, Allen J. Dozor  Journal of Cystic Fibrosis 
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Volume 137, Issue 3, Pages (September 2009)
Raphaël Chiron, Y. Yaël Grumbach, Nga V. T
Assessment of CFTR function in homozygous R117H-7T subjects
Cirrhosis and other liver disease in cystic fibrosis
The ease of breathing test tracks clinical changes in cystic fibrosis
Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking  Graeme W. Carlile, Renaud Robert, Julie Goepp, Elizabeth Matthes,
Fiona K. Dunlevy, S. Lorraine Martin, Francine de Courcey, J
Controlled clinical trials in cystic fibrosis — are we doing better?
Exocrine cell-derived microparticles in response to lipopolysaccharide promote endocrine dysfunction in cystic fibrosis  Andrei Alexandru Constantinescu,
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial  S.K. Kabra, R. Pawaiya, Rakesh Lodha,
Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn 
Amyloidosis in cystic fibrosis: A case series
Mechanism of direct bicarbonate transport by the CFTR anion channel
Combination potentiator (‘co-potentiator’) therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators 
A.H. Gifford  Journal of Cystic Fibrosis 
Shaoyan Zhang, Neel K. Ranganath, Daniel Skinner, David M
Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis  Sanja Stanojevic, Valerie Waters, Joseph L.
Inhalation solutions — Which ones may be mixed
Partial Inhibition of Sarcoplasmic Reticulum Ca Release Evokes Long-Lasting Ca Release Events in Ventricular Myocytes: Role of Luminal Ca in Termination.
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment 
Transepithelial fluctuation analysis of chloride secretion
Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients  E.B. Wilms, D.J. Touw, H.G.M. Heijerman 
Stimulation of salivary secretion in vivo by CFTR potentiators in Cftr+/+ and Cftr−/− mice  Sabrina Noël, Pierre-Olivier Strale, Luc Dannhoffer, Martina.
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
R. Dekkers, L. A. W. Vijftigschild, A. M. Vonk, E. Kruisselbrink, K. M
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
A new method of sweat testing: the CF Quantum®sweat test
Dr Brian J. Harvey, Maria Higgins  Kidney International 
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation  Noa Nezer M. Sc, David Shoseyov, Eitan.
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis  Ahmet Z. Uluer, David A. Waltz, Leslie.
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Safety assessment of inhaled xylitol in subjects with cystic fibrosis
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Uta Griesenbach, A. Christopher Boyd  Journal of Cystic Fibrosis 
Presentation transcript:

P. aeruginosa LPS stimulates calcium signaling and chloride secretion via CFTR in human bronchial epithelial cells  J.M. Buyck, V. Verriere, R. Benmahdi, G. Higgins, B. Guery, R. Matran, B.J. Harvey, K. Faure, V. Urbach  Journal of Cystic Fibrosis  Volume 12, Issue 1, Pages 60-67 (January 2013) DOI: 10.1016/j.jcf.2012.06.007 Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Source of calcium involved in [Ca²+]i increase induced by P. aeruginosa LPS. A. Typical effect of LPS (30μg/ml) on F340/380 ratio in Krebs solution (solid line) or external calcium-free solution (dotted line). B. Typical effect of thapsigargin pretreatment (15min, 50μM) on the LPS (30μg/ml) induced F340/380 ratio changes measured in Krebs solution (solid line) or calcium-free solution (dotted line). C. Means of maximal F340/380 ratio changes (peak) induced by LPS (30μg/mL) in Krebs solution (CTL), calcium-free solution (Ca-free), upon exposure to 50μM thapsigargin (Tg) in Krebs solution and upon exposure to 50μM thapsigargin in calcium-free solution (Tg+Ca-free). Data are means±SEM (n=5); **: p<0.01; ***: p<0.001 statistically different from CTL. D. Means AUC obtained upon LPS (30μg/ml) exposure in Krebs solution (CTL), in calcium-free solution (Ca-free), in Krebs solution with 50μM of thapsigargin (Tg) and in calcium-free solution with 50μM of thapsigargin (Tg+Ca-free). Data are means±SEM (n=5); *: p<0.05; ***: p<0.001 statistically different from CTL. Journal of Cystic Fibrosis 2013 12, 60-67DOI: (10.1016/j.jcf.2012.06.007) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Effect of calcium channel inhibitors and suramin on the calcium response induced by P. aeruginosa LPS. A. Mean of the maximum F340/380 ratio increases (peak) induced by LPS (30μg/ml) in Krebs solution (CTL), or in presence of calcium channel inhibitors (LaCl3: 1μM, GdCl3: 1μM, SKF96365: 3μM, Econazole: 30μM, Ruthenium Red: 10μM, Verapamil: 0.1μM and 2-APB: 10μM). Data are means±SEM (n=5; *: p<0.05; **: p<0.01; statistically different from CTL). B. Means of AUC increase induced by LPS (30μg/ml) in Krebs solution (CTL), or in presence of calcium channel inhibitors. Data are means±SEM (n=5; *: p<0.05; **: p<0.01; statistically different from CTL). C. Mean of maximum F340/380 ratio increases (peak) induced by LPS (30μg/ml) in Krebs solution (CTL), or in presence of suramin (100μM). Data are means±SEM (n=5). D. Mean AUC increase induced by LPS (30μg/ml) in Krebs solution (CTL), or during treatment with suramin (100μM). Data are means±SEM (n=5). Journal of Cystic Fibrosis 2013 12, 60-67DOI: (10.1016/j.jcf.2012.06.007) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 Effect of P. aeruginosa LPS on short-circuit current (scc). A. Typical effect of LPS on the scc measured in Ussing chambers (left) and means of scc values obtained before (CTL) and after exposure to LPS (LPS, 30μg/ml). B. Dose effect of apical (from 10 to 50μg/mL) and basolateral (BL 30, 30μg/mL) application of LPS. Data are mean of the scc variations compared to the basal scc±SEM (n=3). Journal of Cystic Fibrosis 2013 12, 60-67DOI: (10.1016/j.jcf.2012.06.007) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 4 Pharmacological inhibition of scc increase induced by P. aeruginosa LPS. A. Typical effect of LPS in presence of amiloride (left) and mean of variation of scc (Δ scc±SEM, n=5) (right). B. Typical effects of NPPB (100μM), DPC (100μM) and Glibenclamide (100μM) on scc increase induced by LPS (30μg/ml) (left) and mean variation of scc (Δ scc±SEM; n=5; *: p<0.05, **: p<0.01) (right). C. Typical effects of CFTR(inh)-172 and forskolin (10μM) on the scc increase induced by LPS (30μg/ml) (left), and mean of variation of scc (Δ scc±SEM; n=5; *: p<0.05) (right). Journal of Cystic Fibrosis 2013 12, 60-67DOI: (10.1016/j.jcf.2012.06.007) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 5 Role of intracellular calcium modulators on the scc induced by P. aeruginosa LPS. Typical effects of BAPTA (50μM), 2-APB (10μM), SKF96365 (3μM) and GdCl3 (1μM) on the scc before and after exposure to LPS (30μg/ml) (left). Mean of variation of scc induced by LPS after BAPTA (n=5), 2-APB (n=5), SKF96365 (n=3) and GdCl3 (n=4). *: p<0.05, **: p<0.001 (right). Journal of Cystic Fibrosis 2013 12, 60-67DOI: (10.1016/j.jcf.2012.06.007) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions